+ POLICY — Keir Starmer has said ministers should be able to “look every parent in the eye” and pledge that tech can cre…− POLICY — Artificial intelligence poses a “Hiroshima”-style risk to humanity if governments do not agree to curb how it…− CLIMATE — Artificial intelligence is often associated with ludicrous amounts of electricity, and therefore planet-heati…− EDUCATION — While many schools in England have banned smartphones, in Estonia – regarded as the new European education po…− EDUCATION — In a Cambridge classroom, Joseph, 10, trained his AI model to discern between drawings of apples and drawings…− EDUCATION — OpenAI CEO Sam Altman recently told a US podcast that if he was graduating today, “I would feel like the luck…+ EDUCATION — I disagree with the decision of lecturers to use artificial intelligence to create teaching materials (‘We co…− BUSINESS — Americans are growing worried about what artificial intelligence portends for their futures. Eight in 10 Amer…
TruaceTracing the truth around AISunday, July 12, 2026
Subscribe
Health·P Space·Evidence-backed problem·Published 2026-07-12

Evolut r transcatheter aortic valve: FDA injury report involving AI

The FDA received a injury report involving Evolut r transcatheter aortic valve, made by Medtronic mexico s. de r.l. de cv. It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure.

TRV-2026-0047Official statisticsPermanent record — cite & verify
Evolut r transcatheter aortic valve: FDA injury report involving AI

"Medical Laboratory" by ben.dracup, CC BY 2.0.

Main points
  • Device: Evolut r transcatheter aortic valve; manufacturer: Medtronic mexico s. de r.l. de cv.
  • FDA report type: Injury.
  • An adverse-event report is a safety signal, not proof that the device caused the event.
Problem

An FDA adverse-event report linked Evolut r transcatheter aortic valve to an AI-related injury; the report requires investigation and does not by itself establish causality.

The rundown

It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure.

The report is part of FDA’s MAUDE surveillance data. It should be read as a signal for follow-up, not a clinical conclusion or a verified incidence rate.

Sources

The debate